OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 57.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,000 shares of the semiconductor company’s stock after selling 10,801 shares during the period. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Synopsys were worth $3,758,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also modified their holdings of SNPS. Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Synopsys in the 4th quarter valued at $28,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Synopsys in the 4th quarter valued at $28,000. Atlas Capital Advisors Inc. acquired a new position in shares of Synopsys in the 4th quarter valued at $32,000. Oakworth Capital Inc. lifted its stake in shares of Synopsys by 3,700.0% in the 4th quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company’s stock valued at $36,000 after purchasing an additional 74 shares during the last quarter. Finally, Greenline Wealth Management LLC acquired a new position in shares of Synopsys in the 4th quarter valued at $37,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Price Performance
SNPS opened at $454.38 on Tuesday. The stock’s 50-day moving average price is $474.73 and its 200 day moving average price is $461.19. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 12-month low of $376.18 and a 12-month high of $651.73. The firm has a market cap of $87.00 billion, a price-to-earnings ratio of 105.18, a PEG ratio of 2.67 and a beta of 1.22.
Analysts Set New Price Targets
Several equities analysts recently issued reports on SNPS shares. Citigroup increased their target price on Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Morgan Stanley increased their target price on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. BNP Paribas Exane increased their target price on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Stifel Nicolaus increased their target price on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Finally, The Goldman Sachs Group set a $600.00 target price on Synopsys and gave the stock a “buy” rating in a research note on Wednesday, February 25th. Nine research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $563.81.
Check Out Our Latest Stock Analysis on Synopsys
Insider Transactions at Synopsys
In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by corporate insiders.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
